Thomas Blomquist

1.9k total citations
33 papers, 436 citations indexed

About

Thomas Blomquist is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas Blomquist has authored 33 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas Blomquist's work include RNA modifications and cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Molecular Biology Techniques and Applications (6 papers). Thomas Blomquist is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer Genomics and Diagnostics (8 papers) and Molecular Biology Techniques and Applications (6 papers). Thomas Blomquist collaborates with scholars based in United States, Germany and Australia. Thomas Blomquist's co-authors include James C. Willey, Erin L. Crawford, D. V. Priola, Adarli Romero, Darren M. Gordon, Terry D. Hinds, Robert E. McCullumsmith, David E. Stec, Ji‐Youn Yeo and Sadik Khuder and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Thomas Blomquist

32 papers receiving 430 citations

Peers

Thomas Blomquist
Ludivine Renaud United States
James R. Jeter United States
Ok‐Hee Lee South Korea
Joseph Gawdzik United States
Thomas Blomquist
Citations per year, relative to Thomas Blomquist Thomas Blomquist (= 1×) peers Xiaodong Zhao

Countries citing papers authored by Thomas Blomquist

Since Specialization
Citations

This map shows the geographic impact of Thomas Blomquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Blomquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Blomquist more than expected).

Fields of papers citing papers by Thomas Blomquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Blomquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Blomquist. The network helps show where Thomas Blomquist may publish in the future.

Co-authorship network of co-authors of Thomas Blomquist

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Blomquist. A scholar is included among the top collaborators of Thomas Blomquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Blomquist. Thomas Blomquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamouda, Danae, et al.. (2023). Metastatic Clear Cell-Renal Cell Carcinoma in Birt-Hogg-Dube Syndrome. JU Open Plus. 1(9).
2.
Willey, James C., Tom Morrison, Erin L. Crawford, et al.. (2021). Advancing NGS quality control to enable measurement of actionable mutations in circulating tumor DNA. Cell Reports Methods. 1(7). 100106–100106. 11 indexed citations
3.
Mehrotra, Aanchal, Caitlin E. Baum, Brandon Lewis, et al.. (2020). Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation. Epigenetics & Chromatin. 13(1). 14–14. 15 indexed citations
4.
Yeo, Ji‐Youn, et al.. (2020). Whole-Genome Sequencing of Bacterial Isolates That Degrade the Cyanobacterial Toxin Microcystin-LR. Microbiology Resource Announcements. 9(40). 5 indexed citations
5.
Breidenbach, Joshua D., Apurva Lad, Thomas Blomquist, et al.. (2020). CD40 Receptor Knockout Protects against Microcystin-LR (MC-LR) Prolongation and Exacerbation of Dextran Sulfate Sodium (DSS)-Induced Colitis. Biomedicines. 8(6). 149–149. 9 indexed citations
6.
Blomquist, Thomas, Erin L. Crawford, James C. Willey, & Joshua Xu. (2019). Abstract 3539: Impact of formalin time on targeted NGS performance in FFPE tissue. Cancer Research. 79(13_Supplement). 3539–3539. 1 indexed citations
7.
Craig, Daniel J., Thomas Morrison, Sadik Khuder, et al.. (2019). Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells. BMC Cancer. 19(1). 1081–1081. 8 indexed citations
8.
Blomquist, Thomas, Andrew L. Kleinhenz, Prabhatchandra Dube, et al.. (2019). Exposure to the Harmful Algal Bloom (HAB) Toxin Microcystin-LR (MC-LR) Prolongs and Increases Severity of Dextran Sulfate Sodium (DSS)-Induced Colitis. Toxins. 11(6). 371–371. 31 indexed citations
9.
Lad, Apurva, Joshua D. Breidenbach, Thomas Blomquist, et al.. (2019). Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD). PLoS ONE. 14(12). e0225604–e0225604. 20 indexed citations
10.
Gunning, William T., Beverly Karabin, Thomas Blomquist, & Blair P. Grubb. (2016). Postural orthostatic tachycardia syndrome is associated with platelet storage pool deficiency. Medicine. 95(37). e4849–e4849. 11 indexed citations
11.
Blomquist, Thomas, Erin L. Crawford, Ji‐Youn Yeo, Xiaolu Zhang, & James C. Willey. (2015). Control for stochastic sampling variation and qualitative sequencing error in next generation sequencing. SHILAP Revista de lepidopterología. 5. 30–37. 14 indexed citations
12.
Yeo, Ji‐Youn, Erin L. Crawford, Thomas Blomquist, et al.. (2014). A Multiplex Two-Color Real-Time PCR Method for Quality-Controlled Molecular Diagnostic Testing of FFPE Samples. PLoS ONE. 9(2). e89395–e89395. 7 indexed citations
13.
Crawford, Erin L., et al.. (2013). Quality Control Methods for Optimal BCR-ABL1 Clinical Testing in Human Whole Blood Samples. Journal of Molecular Diagnostics. 15(3). 391–400. 7 indexed citations
14.
Blomquist, Thomas, Erin L. Crawford, Jennie L. Lovett, et al.. (2013). Targeted RNA-Sequencing with Competitive Multiplex-PCR Amplicon Libraries. PLoS ONE. 8(11). e79120–e79120. 24 indexed citations
16.
Blomquist, Thomas, Erin L. Crawford, Sadik Khuder, et al.. (2009). Pattern of Antioxidant and DNA Repair Gene Expression in Normal Airway Epithelium Associated with Lung Cancer Diagnosis. Cancer Research. 69(22). 8629–8635. 41 indexed citations
17.
Crawford, Erin L., et al.. (2007). CEBPG regulates ERCC5/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1/YY1 interactions. Carcinogenesis. 28(12). 2552–2559. 33 indexed citations
18.
Collins, Elaine D., et al.. (2002). Flexibility of BIV TAR-Tat: Models of Peptide Binding. Journal of Biomolecular Structure and Dynamics. 20(2). 243–251. 3 indexed citations
19.
Raizada, Veena, et al.. (1993). Alterations in cardiac myosin isozymes associated with aging and chronic hypertension: their modulation with nifedipine. Cardiovascular Research. 27(10). 1869–1872. 5 indexed citations
20.
Blomquist, Thomas & D. V. Priola. (1992). Tachyphylaxis of the intrinsic cardiac nerves to nicotine: effects on A‐V nodal conduction. Journal of Autonomic Pharmacology. 12(1). 51–59. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026